Business
Laborie Announces Agreement to Acquire the JADA® System from Organon
Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. ("Laborie") announced it has entered into an agreement with Organon, a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, to acquire the JADA® System, an innovative FDA-cleared device for the rapid control and treatment of abnormal postpartum uterine bleeding or hemorrhage, when conservative management is warranted. The JADA System has lau
About this update from Organon & Co.
[{"type":"text","content":"The acquisition expands Laborie's obstetrics portfolio and demonstrates the company's commitment to delivering innovative, proven solutions to physicians and patients globally. ","length":184,"tagName":"p"},{"type":"text","content":"PORTSMOUTH, N.H., Nov. 7, 2025 /PRNewswire/ -- Leading diagnostic and therapeutic medical technology company Laborie Medical Technologies Corp. ("Laborie") announced it has entered into an agreement with Organon, a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, to acquire the JADA® System, an innovative FDA-cleared device for the rapid control and treatment of abnormal postpartum uterine bleeding or hemorrhage, when conservative management is warranted. The JADA System has launched in over 20 countries and is currently available in more than 2,000 hospitals across the United States.","length":665,"tagName":"p"},{"type":"text","content":"The transaction, valued up to $465 million, is comprised of $440 million paid at closing and includes a milestone payment of up to $25 million subject to the achievement of certain 2026 revenue targets. The transaction is expected to close in the first quarter of 2026, subject to closing conditions and regulatory approvals.","length":325,"tagName":"p"},{"type":"text","content":""Childbirth is one of the most personal and profound moments in a woman's life, and every mother deserves to feel supported throughout it. The JADA System helps care teams provide treatment when it matters most and being part of that mission is something we hold with deep pride and purpose at Laborie." said Chris Smith, President and CEO of Laborie. "We are equally inspired by the dedication and strength of the commercial team behind the JADA and we are excited to have them join Laborie to help accelerate our growth in the obstetrics market."","length":572,"tagName":"p"},{"type":"text","content":""I am incredibly proud of the work the JADA team and Organon have done to help more than 136,000 mothers in over 20 countries and position JADA as a recognized standard of care in postpartum hemorrhage (PPH) management" said Organon interim Chief Executive Officer (CEO) Joseph Morrissey. "This transaction puts a med tech asset in the hands of Laborie, a leading medical technology i...